Z-Tech, Inc. - Breast Cancer Screening

A pivotal international clinic trial is now in progress to validate, in thousands of women, the diagnostic accuracy and safety of the HEDA™ breast scan method for screening breast cancer.

Z-Tech is sponsoring this large multi-site clinical study in hospitals and primary care physician groups in the United States, Canada and Europe to obtain regulatory approval for the breast scan in these regions. The study is designed to compare the diagnostic accuracy of Z-Tech's HEDA method for breast cancer screening to that of screening mammography.

Clinical trial sites include:


Medical University of South Carolina Charleston, SC	Massachusetts General Hospital Boston, MA

Lahey Clinic Burlington, MA	Obstetrical & Gynecological Assoc. Houston, TX

Charité Hospital Berlin, Germany	Policlinico Gemelli Rome, Italy

Princess Grace Hospital London, England	Mt. Sinai Hospital Toronto, Canada

Lexington Medical Center Columbia, SC	Indiana University School of Medicine, Indianapolis, IN

University of Connecticut Health Center, Farmington, CT	Wake Forest University School of Medicine, Winston-Salem, NC

Beth Israel Medical Center New York, NY	St. Mary Medical Center Langhorne, PA
Not shown, the following sites: Karmanos Cancer Institute, Detroit, MI Nashville Breast Center, Nashville, TN Medical College of Georgia, Augusta, GA Breast Care Specialists, Roanoke, VA

The Z-Tech Breast Cancer System is presently limited to investigational use in clinical trials only. Copyright © 2007 Z-Tech® Inc. All rights reserved.

The Z-Tech Breast Cancer System is presently limited to investigational use in clinical trials only.
Copyright © 2007 Z-Tech^® Inc. All rights reserved.